Cochlear Ltd just made a $50 million bet on China

The Cochlear Ltd (ASX:COH) share price is rising on news it will invest in China.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Cochlear Ltd (ASX: COH) share price is up 2.5% to $153.60 this afternoon after the hearing implant manufacturer announced it is to "deepen its commitment" to China by spending $50 million to construct a manufacturing facility in the country.

China is already among Cochlear's top five international markets and is its fastest growing market by volume, with potential to deliver more strong growth over the next decade.

However, it's also a politically complex market with the company largely reliant on government favour to meet its giant reimbursement bills as cut-price competitors also seek to win government tenders for hearing implant devices.

China also has a private patient market, but the government tenders remain key and investing $50 million in the country is likely to be met with approval by the one-party state. The deal has been agreed with the People's Government of Chengdu City where the facility is to be built and on completion it is expected to deliver capacity to increase "global cochlear implant production by around 50 percent".

The deal looks a shrewd long-term move by Cochlear's management team and in my opinion it remains among the top five growth stocks on the ASX. It's no secret though with the stock trading on around 40x analysts' expectations for earnings per share in FY 2017.

I expect the company will need to deliver another year of earnings growth above 15% in FY 2018 to justify today's valuation, which means there's some downside risk if its growth disappoints over the short term. Over the long term though it should reward investors with today's China deal a good example of its global growth potential supported by a profit moat derived from its market-leading technology.

Motley Fool contributor Tom Richardson owns shares of Cochlear Ltd. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »